| 000 | 01523 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515021222.0 | ||
| 264 | 0 | _c20060710 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0022-3549 | ||
| 024 | 7 |
_a10.1002/jps.20614 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJantratid, E | |
| 245 | 0 | 0 |
_aBiowaiver monographs for immediate release solid oral dosage forms: cimetidine. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cMay 2006 |
||
| 300 |
_a974-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry, Physical |
| 650 | 0 | 4 |
_aCimetidine _xadministration & dosage |
| 650 | 0 | 4 | _aDosage Forms |
| 650 | 0 | 4 | _aEsters |
| 650 | 0 | 4 | _aExcipients |
| 650 | 0 | 4 |
_aHistamine H2 Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsomerism |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSalts |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aPrakongpan, S | |
| 700 | 1 | _aDressman, J B | |
| 700 | 1 | _aAmidon, G L | |
| 700 | 1 | _aJunginger, H E | |
| 700 | 1 | _aMidha, K K | |
| 700 | 1 | _aBarends, D M | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 95 _gno. 5 _gp. 974-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.20614 _zAvailable from publisher's website |
| 999 |
_c16165106 _d16165106 |
||